SAFETY AND EFFICACY OF LENABASUM IN AN OPEN-LABEL EXTENSION OF A PHASE 2 STUDY IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS SUBJECTS (DCSSC)

被引：2
|
作者：
Spiera, Robert [1 ]
Hummers, Laura [2 ]
Chung, Lorinda [3 ]
Frech, Tracy [4 ]
Domsic, Robin [5 ]
Hsu, Vivian [6 ]
Furst, Daniel [7 ,8 ]
Gordon, Jessica [1 ]
Mayes, Maureen [9 ]
Simms, Robert [10 ]
Lee, Elizabeth [11 ]
Constantine, Scott [11 ]
Dgetluck, Nancy [11 ]
White, Barbara [11 ]
机构：
[1] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA
[2] Johns Hopkins, Baltimore, MD USA
[3] Stanford Univ, Palo Alto, CA 94304 USA
[4] Univ Utah, Salt Lake City, UT USA
[5] Univ Pittsburgh, Pittsburgh, PA USA
[6] Univ Med & Dent New Jersey, New Brunswick, NJ USA
[7] Pacific Arthrit Associates, Los Angeles, CA USA
[8] Univ Calif Los Angeles, Los Angeles, CA USA
[9] Univ Texas Houston, Houston, TX USA
[10] Boston Univ, Boston, MA 02215 USA
[11] Corbus Pharmaceut Inc, Norwood, MA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.3390
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0325
引用
收藏
页码：245 / 245
页数：1
相关论文
共 50 条
  • [21] A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
    Derk, Chris T.
    Grace, Elizabeth
    Shenin, Max
    Naik, Manisha
    Schulz, Steffan
    Xiong, Wen
    RHEUMATOLOGY, 2009, 48 (12) : 1595 - 1599
  • [22] Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study
    Gleich, Gerald J.
    Roufosse, Florence
    Chupp, Geoffrey
    Faguer, Stanislas
    Walz, Bastian
    Reiter, Andreas
    Yancey, Steven W.
    Bentley, Jane H.
    Steinfeld, Jonathan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (12): : 4431 - +
  • [23] MAINTENANCE OF EFFICACY, SAFETY AND TOLERABILITY OF ARMODAFINIL: AN OPEN-LABEL EXTENSION STUDY
    Black, J.
    Hull, S. G.
    Tiller, J.
    Yang, R.
    Harsh, J. R.
    SLEEP, 2009, 32 : A139 - A139
  • [24] Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study
    Steinfeld, J.
    Gleich, G. J.
    Roufosse, F.
    Chupp, G.
    Faguer, S.
    Reiter, A.
    Walz, B.
    Bentley, J. H.
    Bradford, E. S.
    Yancey, S. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [25] Safety and efficacy of lenabasum in refractory skin-predominant dermatomyositis subjects treated on an open-label extension of trial JBT101-DM-001
    Werth, V. P.
    Pearson, D.
    Okawa, J.
    Feng, R.
    Concha, J.
    Patel, B.
    Hejazi, E.
    Cornwall, C.
    Constantine, S.
    White, B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S105 - S105
  • [26] Safety and Efficacy of Lenabasum in Refractory Skin-Predominant Dermatomyositis Subjects Treated on an Open-Label Extension of Trial JBT101-DM-001
    Werth, Victoria P.
    Pearson, David
    Okawa, Joyce
    Feng, Rui
    Concha, Josef
    Patel, Basil
    Hejazi, Emily
    Cornwall, Caitlin
    Constantine, Scott
    White, Barbara
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [27] PERFORMANCE OF AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) COMBINED RESPONSE INDEX IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (CRISS) SCORE IN PHASE 2 TRIAL OF LENABASUM IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSS)
    Spiera, Robert
    Khanna, Dinesh
    Dgetluck, Nancy
    Conley, Brian
    White, Barbara
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 107 - 107
  • [28] Imatinib mesylate (Gleevec™) in the treatment of diffuse cutaneous systemic sclerosis: results of a 24-month open-label, extension phase, single-centre trial
    Gordon, J.
    Udeh, U.
    Doobay, K.
    Magro, C.
    Wildman, H.
    Davids, M.
    Mersten, J. N.
    Huang, W. -T.
    Lyman, S.
    Crow, M. K.
    Spiera, R. F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (06) : S189 - S193
  • [29] Imatinib Mesylate (Gleevec™) in the Treatment of Diffuse Cutaneous Systemic Sclerosis: Results of a 24 Month Open Label, Extension Phase.
    Gordon, Jessica K.
    Davids, Morgana L.
    Doobay, Kamini
    Mersten, Jamie N.
    Magro, Cynthia
    Wildman, Horatio F.
    Lyman, Stephen L.
    Crow, Mary K.
    Spiera, Robert F.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S735 - S735
  • [30] Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis: Results from the Open-Label Period of a Phase 3 Trial
    Khanna, Dinesh
    Lin, Celia J. F.
    Spotswood, Helen
    Siegel, Jeffrey
    Furst, Daniel
    Denton, Christopher
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
12345